OTTAWA, Ontario–The Prime Minister, Justin Trudeau, today announced $220 million in additional funding to support COVID-19 vaccination needs in lower income countries. This additional support builds on the more than $2.7 billion Canada has provided for international assistance in response to COVID-19. It will address barriers to access to COVID-19 vaccines and improve the capacity of lower-income countries to distribute vaccines by ensuring that countries have the financial, operational and technical support they need to get people vaccinated.
Canada is playing a lead role in ending the pandemic by working with international partners to address barriers and support equitable access to life-saving vaccines, tests, and treatments. We continue to demonstrate our commitment to the COVAX Facility through our work as the Co-Chair of the Advance Market Commitment (AMC) Engagement Group, our financial commitments, improving vaccine donation management, and delivering the equivalent of over 100 million doses – with more to come.
“Since the start of the pandemic, we have known that to truly end this pandemic anywhere, we have to end it everywhere. Canada will continue to be among the world leaders in improving access to COVID-19 vaccines and coordinating global action to end this pandemic to ensure everyone has a fair chance to build a better future in the years ahead.”
“From the start, Canada knew that the COVAX Facility was the best way to get vaccines to countries who need them the most. We will continue to work with COVAX not only to increase vaccine supply, but also delivery so we can make sure that vaccines can get from airports into arms as quickly as possible.”